RESUMO
Terminal deletions are found frequently in both malignancies and clinically recognizable deletion syndromes in man. Little is known, particularly in cancer, of the specific mechanisms which lead to the generation of deleted chromosomes or the process by which these broken chromosomes are stabilized. We demonstrate that several examples of apparent terminal deletions are, in fact, subtelomeric translocations which were not detectable using conventional cytogenetics. The unexpectedly high frequency of this phenomenon and the diversity of partner chromosomes involved in the subtelomeric translocations is consistent with a model in which telomere capture can stabilize chromosome breakage in man.
Assuntos
Deleção Cromossômica , Telômero/ultraestrutura , Cromossomos Humanos Par 6 , Humanos , Células Híbridas/ultraestrutura , Hibridização in Situ Fluorescente , Melanoma/genética , Melanoma/ultraestrutura , Modelos Genéticos , Translocação GenéticaRESUMO
The strategy presented here to identify unequivocally cryptic chromosomal rearrangements has relevance to both prenatal and postnatal cytogenetic analysis as well as the analysis of tumour-associated chromosome rearrangements. Microdissection and in vitro amplification of specific chromosomal regions are performed, followed by labelling for fluorescent in situ hybridization (FISH) to normal metaphase chromosomes (Micro-FISH). Micro-FISH probes have been used successfully to determine the derivation of chromosome segments unidentifiable by standard chromosome banding analysis. Micro-FISH probes (created in less than 24 hours) now make it possible to identify explicitly the chromosome constitution of virtually all cytologically visible chromosome rearrangements.
Assuntos
Cromossomos Humanos/ultraestrutura , Hibridização in Situ Fluorescente/métodos , Técnicas de Sonda Molecular , Sequência de Bases , Aberrações Cromossômicas , Deleção Cromossômica , DNA/genética , Sondas de DNA , Feminino , Rearranjo Gênico , Humanos , Dados de Sequência Molecular , Neoplasias/genética , Reação em Cadeia da Polimerase , Gravidez , Diagnóstico Pré-Natal , Translocação GenéticaRESUMO
We have performed microdissection of 16 putative homogeneously staining regions (hsrs) from nine different breast cancer cell lines in order to determine their chromosomal origin and composition. As expected, the most commonly amplified chromosomal band-region was 17q12 (containing ERBB2). However, regions not containing known oncogenes were also identified, including 13q31 (5/9 cases) and 20q12-13.2 (4/9 cases). The chromosomal composition of the integrated amplified DNA within each hsr was determined and in 13/16 cases (81%), hsrs were shown to be composed of two or more chromosomal regions. These studies shed light on the mechanism of formation of hsrs, and identify chromosomal regions likely to harbour genes amplified in breast cancer.
Assuntos
Neoplasias da Mama/genética , Cromossomos Humanos/ultraestrutura , Amplificação de Genes , Hibridização in Situ Fluorescente/métodos , Micromanipulação , Sequência de Bases , Bandeamento Cromossômico , Cromossomos Humanos Par 13/ultraestrutura , Cromossomos Humanos Par 17/ultraestrutura , Cromossomos Humanos Par 20/ultraestrutura , Feminino , Humanos , Dados de Sequência Molecular , Oncogenes , Células Tumorais CultivadasRESUMO
The development and progression of cancer and the experimental reversal of tumorigenicity are accompanied by complex changes in patterns of gene expression. Microarrays of cDNA provide a powerful tool for studying these complex phenomena. The tumorigenic properties of a human melanoma cell line, UACC-903, can be suppressed by introduction of a normal human chromosome 6, resulting in a reduction of growth rate, restoration of contact inhibition, and suppression of both soft agar clonogenicity and tumorigenicity in nude mice. We used a high density microarray of 1,161 DNA elements to search for differences in gene expression associated with tumour suppression in this system. Fluorescent probes for hybridization were derived from two sources of cellular mRNA [UACC-903 and UACC-903(+6)] which were labelled with different fluors to provide a direct and internally controlled comparison of the mRNA levels corresponding to each arrayed gene. The fluorescence signals representing hybridization to each arrayed gene were analysed to determine the relative abundance in the two samples of mRNAs corresponding to each gene. Previously unrecognized alterations in the expression of specific genes provide leads for further investigation of the genetic basis of the tumorigenic phenotype of these cells.
Assuntos
Expressão Gênica , Técnicas Genéticas , Melanoma/genética , Animais , Cromossomos Humanos Par 6 , Sondas de DNA , DNA Complementar , Humanos , Camundongos , Camundongos Nus , RNA Mensageiro/metabolismo , Células Tumorais CultivadasRESUMO
Alagille syndrome (AGS) is an autosomal-dominant disorder characterized by intrahepatic cholestasis and abnormalities of heart, eye and vertebrae, as well as a characteristic facial appearance. Identification of rare AGS patients with cytogenetic deletions has allowed mapping of the gene of 20p12. We have generated a cloned contig of the critical region and used fluorescent in situ hybridization on cells from patients with submicroscopic deletions to narrow the candidate region to only 250 kb. Within this region we identified JAG1, the human homologue of rat Jagged1, which encodes a ligand for the Notch receptor. Cell-cell Jagged/Notch interactions are known to be critical for determination of cell fates in early development, making this an attractive candidate gene for a developmental disorder in humans. Determining the complete exon-intron structure of JAG1 allowed detailed mutational analysis of DNA samples from non-deletion AGS patients, revealing three frame-shift mutations, two splice donor mutations and one mutation abolishing RNA expression from the altered allele. We conclude that AGS is caused by haploinsufficiency of JAG1.
Assuntos
Síndrome de Alagille/genética , Proteínas de Membrana/genética , Receptores de Superfície Celular , Fatores de Transcrição , Proteínas de Ligação ao Cálcio , Linhagem Celular , Mapeamento Cromossômico , Cromossomos Humanos Par 20/genética , Clonagem Molecular , Análise Mutacional de DNA , Primers do DNA , Éxons/genética , Regulação da Expressão Gênica no Desenvolvimento/genética , Humanos , Hibridização in Situ Fluorescente , Peptídeos e Proteínas de Sinalização Intercelular , Íntrons/genética , Proteína Jagged-1 , Proteínas de Membrana/química , Proteínas de Membrana/metabolismo , Mutação , Polimorfismo Conformacional de Fita Simples , Splicing de RNA/genética , Receptor Notch1 , Análise de Sequência de DNA , Deleção de Sequência/genética , Proteínas Serrate-JaggedRESUMO
The purpose of this study was to develop a method of classifying cancers to specific diagnostic categories based on their gene expression signatures using artificial neural networks (ANNs). We trained the ANNs using the small, round blue-cell tumors (SRBCTs) as a model. These cancers belong to four distinct diagnostic categories and often present diagnostic dilemmas in clinical practice. The ANNs correctly classified all samples and identified the genes most relevant to the classification. Expression of several of these genes has been reported in SRBCTs, but most have not been associated with these cancers. To test the ability of the trained ANN models to recognize SRBCTs, we analyzed additional blinded samples that were not previously used for the training procedure, and correctly classified them in all cases. This study demonstrates the potential applications of these methods for tumor diagnosis and the identification of candidate targets for therapy.
Assuntos
Perfilação da Expressão Gênica , Neoplasias/classificação , Neoplasias/diagnóstico , Redes Neurais de Computação , Análise de Sequência com Séries de Oligonucleotídeos , Linfoma de Burkitt/classificação , Linfoma de Burkitt/diagnóstico , Linfoma de Burkitt/genética , Interpretação Estatística de Dados , Humanos , Modelos Biológicos , Neoplasias/genética , Neuroblastoma/classificação , Neuroblastoma/diagnóstico , Neuroblastoma/genética , Rabdomiossarcoma/classificação , Rabdomiossarcoma/diagnóstico , Rabdomiossarcoma/genética , Sarcoma de Ewing/classificação , Sarcoma de Ewing/diagnóstico , Sarcoma de Ewing/genética , Células Tumorais CultivadasRESUMO
Members of the recently recognized SRC-1 family of transcriptional coactivators interact with steroid hormone receptors to enhance ligand-dependent transcription. AIB1, a member of the SRC-1 family, was cloned during a search on the long arm of chromosome 20 for genes whose expression and copy number were elevated in human breast cancers. AIB1 amplification and overexpression were observed in four of five estrogen receptor-positive breast and ovarian cancer cell lines. Subsequent evaluation of 105 unselected specimens of primary breast cancer found AIB1 amplification in approximately 10 percent and high expression in 64 percent of the primary tumors analyzed. AIB1 protein interacted with estrogen receptors in a ligand-dependent fashion, and transfection of AIB1 resulted in enhancement of estrogen-dependent transcription. These observations identify AIB1 as a nuclear receptor coactivator whose altered expression may contribute to development of steroid-dependent cancers.
Assuntos
Neoplasias da Mama/genética , Amplificação de Genes , Neoplasias Hormônio-Dependentes/genética , Neoplasias Ovarianas/genética , Receptores de Estrogênio/metabolismo , Sequência de Aminoácidos , Mama/metabolismo , Neoplasias da Mama/metabolismo , Cromossomos Humanos Par 20 , Clonagem Molecular , Estradiol/metabolismo , Estradiol/farmacologia , Feminino , Dosagem de Genes , Regulação Neoplásica da Expressão Gênica , Histona Acetiltransferases , Humanos , Hibridização in Situ Fluorescente , Ligantes , Dados de Sequência Molecular , Neoplasias Hormônio-Dependentes/metabolismo , Coativador 1 de Receptor Nuclear , Coativador 2 de Receptor Nuclear , Neoplasias Ovarianas/metabolismo , Receptores de Estrogênio/genética , Fatores de Transcrição/genética , Ativação Transcricional , Transfecção , Células Tumorais CultivadasRESUMO
BACKGROUND: The normal growth and function of mammary epithelial cells depend on interactions with the supportive stroma. Alterations in this communication can lead to the progression or expansion of malignant growth. The human mammary gland contains two distinctive types of fibroblasts within the stroma. The epithelial cells are surrounded by loosely connected intralobular fibroblasts, which are subsequently surrounded by the more compacted interlobular fibroblasts. The different proximity of these fibroblasts to the epithelial cells suggests distinctive functions for these two subtypes. In this report, we compared the gene expression profiles between the two stromal subtypes. METHODS: Fresh normal breast tissue was collected from reduction mammoplasty patients and immediately placed into embedding medium and frozen on dry ice. Tissue sections were subjected to laser capture microscopy to isolate the interlobular from the intralobular fibroblasts. RNA was prepared and subjected to microarray analysis using the Affymetrix Human Genome U133 GeneChip. Data was analyzed using the Affy and Limma packages available from Bioconductor. Findings from the microarray analysis were validated by RT-PCR and immunohistochemistry. RESULTS: No statistically significant difference was detected between the gene expression profiles of the interlobular and intralobular fibroblasts by microarray analysis and RT-PCR. However, for some of the genes tested, the protein expression patterns between the two subtypes of fibroblasts were significantly different. CONCLUSION: This study is the first to report the gene expression profiles of the two distinct fibroblast populations within the human mammary gland. While there was no significant difference in the gene expression profiles between the groups, there was an obvious difference in the expression pattern of several proteins tested. This report also highlights the importance of studying gene regulation at both the transcriptional and post-translational level.
Assuntos
Regulação da Expressão Gênica , Glândulas Mamárias Humanas/citologia , Glândulas Mamárias Humanas/metabolismo , Adolescente , Adulto , Feminino , Fibroblastos/metabolismo , Perfilação da Expressão Gênica , Genótipo , Humanos , Fenótipo , Proteínas/genética , Proteínas/metabolismoRESUMO
Microarray technologies enable genome-scale expression measurements. Already proved to be of value for the functional analysis of individual genes and biological processes, the application of expression profiling to disease gene discovery is now growing in importance and practicality.
Assuntos
Testes Genéticos/métodos , Análise de Sequência com Séries de Oligonucleotídeos/métodos , Animais , Mapeamento Cromossômico , DNA/análise , Doenças Genéticas Inatas/genética , Predisposição Genética para Doença/genética , HumanosAssuntos
Aberrações Cromossômicas , Neoplasias/genética , Humanos , Mutação , Rabdomiossarcoma/genéticaRESUMO
HT1080/DR4 (DR4) is a doxorubicin-resistant human fibrosarcoma line that exhibits 150-fold cross-resistance to etoposide but does not overexpress P-glycoprotein (one mechanism of multiple drug resistance). We examined another possible mechanism that could explain resistance to both doxorubicin and etoposide: a quantitative or qualitative alteration in topoisomerase II, the putative nuclear target of these agents. The amount of immunoreactive topoisomerase II present in whole-cell lysates and nuclear extracts was three- to 10-fold lower in DR4 than in HT1080 cells. However, the topoisomerase II in nuclear extracts from both lines was sensitive to the effects of amsacrine (AMSA) and etoposide. Following treatment with AMSA, etoposide, and 5-iminodaunorubicin, topoisomerase II-mediated DNA cleavage in DR4 cells and nuclei was reduced compared with cleavage in HT1080 parent cells and nuclei. The difference between the HT1080 and DR4 lines in AMSA- and 5-iminodaunorubicin-induced cleavage was similar in cells and nuclei and could be due to the lower amount of DR4 topoisomerase II. By contrast, the difference between the HT1080 and DR4 lines in etoposide-induced DNA cleavage was much greater in cells than in nuclei. This finding suggested that cytosolic factors, removed from isolated nuclei, could influence the susceptibility of intact cells to the cytotoxic and DNA-cleaving actions of etoposide. The specific activities of several antioxidant enzymes, components of the cell's defense against free-radical damage that may be produced by doxorubicin or etoposide, were significantly different in HT1080 and DR4 cytosolic extracts. These differences may constitute an additional mechanism of resistance. Regardless, the magnitude of the resistance of DR4 to doxorubicin and etoposide cannot be explained solely on the basis of a topoisomerase II-related mechanism.
Assuntos
DNA Topoisomerases Tipo II/metabolismo , Doxorrubicina/farmacologia , Resistência a Medicamentos , Etoposídeo/farmacologia , Glicoproteínas de Membrana/análise , Membro 1 da Subfamília B de Cassetes de Ligação de ATP , Amsacrina/farmacologia , Catalase/metabolismo , Linhagem Celular , Núcleo Celular/metabolismo , Sondas de DNA , DNA Topoisomerases Tipo II/isolamento & purificação , Resistência a Medicamentos/genética , Fibrossarcoma , Glucosefosfato Desidrogenase/metabolismo , Glutationa Peroxidase/metabolismo , Glutationa Redutase/metabolismo , Glutationa Transferase/metabolismo , Humanos , Cinética , Proteínas de Neoplasias/análise , Superóxido Dismutase/metabolismo , Inibidores da Topoisomerase IIRESUMO
We have investigated 234 tumors of the central nervous system for amplification of 9 different loci from 12q13-14 and report that about 15% of the anaplastic astrocytomas and glioblastomas show amplification at this chromosomal region. The genes most frequently amplified were CDK4 and SAS (18 of 19 cases). MDM2 was coamplified with CDK4 and SAS in 11 tumors while one glioblastoma showed only MDM2 amplification. Some amplicons additionally included GADD153 (9 cases), GLI (6 cases), A2MR (3 cases), and the anonymous locus D12S8 (2 cases). Either MDM2 or CDK4 and SAS showed the highest amplification level in each individual amplicon and amplification of these genes was consistently accompanied by strong overexpression. Our results thus suggest CDK4, SAS, and MDM2 as main targets for the amplification; however, the possibility exists that all amplicons share a common amplified region between MDM2 and CDK4/SAS which might contain one or more as yet unidentified genes.
Assuntos
Astrocitoma/genética , Neoplasias Encefálicas/genética , Cromossomos Humanos Par 12 , Regulação Neoplásica da Expressão Gênica/genética , Glioblastoma/genética , Tumores Neuroectodérmicos Primitivos/genética , Oligodendroglioma/genética , Southern Blotting , Humanos , Reação em Cadeia da PolimeraseRESUMO
A multidrug-resistant variant of the human HL-60 promyelocytic leukemia cell line (HL-60/MX2) has been isolated in vitro by subculturing these cells in progressively increasing concentrations of mitoxantrone. The MX2 cells are cross-resistant to etoposide, teniposide, bisantrene, dactinomycin, 4'-(9-acridinylamino)methanesulfon-m-anisidide, and the anthracyclines daunorubicin and doxorubicin but retain sensitivity to the Vinca alkaloids melphalan and mitomycin C. In addition, the MX2 cells display slight collateral sensitivity to bleomycin. Despite being 30-35-fold less sensitive to mitoxantrone, net [14C]mitoxantrone accumulation at 60 min was reduced by only 10% in the mitoxantrone-resistant cells compared to the parental line. Furthermore, at later time points, e.g., 120 and 180 min, mitoxantrone accumulation in the MX2 cells exceeded that in HL-60 cells by 8.5 and 6.4%, respectively. No significant differences were observed between the sensitive and resistant cell lines in the initial (first 60 s) accumulation of mitoxantrone, and only minor (3-6%) enhancement of mitoxantrone efflux was detected in the resistant cell type. Monoclonal antibodies to P-glycoprotein had no detectable reactivity with membrane vesicles from either the sensitive or resistant cell types as determined by standard immunoblotting techniques. The mitoxantrone-resistant cells displayed a reciprocal translocation [rcpt(1;3)-(q21;p23)] not found in the sensitive parent, but there were no demonstrable double minute chromosomes or homogeneous staining regions in cells from either line. Thus, these mitoxantrone-resistant human leukemia cells display many features which are atypical for the "classic" multidrug resistance phenotype and should provide a useful model for the study of multidrug resistance which is not mediated by P-glycoprotein.
Assuntos
Amplificação de Genes , Cariotipagem , Leucemia/genética , Glicoproteínas de Membrana/genética , Mitoxantrona/metabolismo , Membro 1 da Subfamília B de Cassetes de Ligação de ATP , Antineoplásicos/metabolismo , Resistência a Medicamentos , Humanos , Leucemia/metabolismo , Leucemia/patologia , Células Tumorais Cultivadas/metabolismo , Células Tumorais Cultivadas/patologiaRESUMO
Gene amplification is an important mechanism of increased gene expression in a number of human solid tumors. We have recently identified and cloned sequences from a novel DNA amplification unit in malignant fibrous histiocytoma. The amplified sequences are derived from chromosome 12q13-14 and encode a gene designated SAS (sarcoma amplified sequence). In the present study, a series of soft tissue sarcomas was studied to characterize further the phenomenon of SAS amplification. Seven of 22 (32%) malignant fibrous histiocytomas and three liposarcomas contained SAS amplification. Strikingly, all of the tumors with SAS amplification occurred in central sites (i.e., in the abdominal or inguinal regions) rather than in the extremities (i.e., in the arms of legs). These observations demonstrate that SAS amplification occurs with a significant frequency in mesenchymal tumors and is particularly associated with abdominal disease.
Assuntos
Amplificação de Genes , Histiocitoma Fibroso Benigno/genética , Sarcoma/genética , Neoplasias de Tecidos Moles/genética , Adulto , Idoso , Feminino , Humanos , Masculino , Pessoa de Meia-IdadeRESUMO
Chromosome translocations in human malignancies have identified the genomic location of several important growth-regulatory sequences (e.g., cellular oncogenes and suppressor genes). Melanomas are characterized by recurring chromosome alterations, including deletion or translocations of the long arm of chromosome 6 (6q). This report details our efforts to clone the t(1;6)(q21;q14) breakpoint in a malignant melanoma to further our understanding of the biology of these tumors. The strategy utilized combined microdissection of the translocation chromosome, development and characterization of a DNA microclone library, isolation of cosmids and YACs from the breakpoint region, ordering of clones by two-color metaphase/interphase fluorescence in situ hybridization, and finally, identification of a YAC spanning the translocation breakpoint. By analogy to other tumor systems, molecular examination of the chromosome 6 breakpoint may provide insight into the pathobiology of this important neoplasm.
Assuntos
Aberrações Cromossômicas/genética , Melanoma/genética , Translocação Genética/genética , Adulto , Sequência de Bases , Transtornos Cromossômicos , Cromossomos Artificiais de Levedura , Cromossomos Humanos Par 1 , Cromossomos Humanos Par 6 , Clonagem Molecular , Cosmídeos , Primers do DNA/química , Dissecação , Feminino , Marcadores Genéticos , Biblioteca Genômica , Humanos , Hibridização in Situ Fluorescente , Dados de Sequência MolecularRESUMO
We have reported previously that about 15% of anaplastic astrocytomas and glioblastomas show amplification and overexpression of one or more genes from chromosomal segment 12q13-q15 (G. Reifenberger et al., Cancer Res., 54, 4299-4303, 1994). The genes most frequently amplified and overexpressed were CDK4 (with coamplification of SAS) and MDM2. Because individual malignant gliomas showed CDK4/SAS amplification but no MDM2 amplification and vice versa, the possibility remained of a common amplification target gene located between CDK4 and MDM2. We have addressed this question by performing a detailed amplicon mapping of a series of 24 primary malignant gliomas and two glioblastoma cell lines with 12q13-q15 amplification. All tumors and cell lines were analyzed at eight gene loci and six anonymous loci from 12q13-q15, including seven loci located between CDK4 and MDM2. These studies revealed two centers of amplification, one at CDK4/SAS and the other at MDM2. A number of loci located close to either MDM2 or CDK4/SAS, including the genes GADD153, GLI, RAP1B, A2MR, and IFNG, were found to be coamplified in some tumors but not overexpressed consistently. All amplicons were discontinuous between CDK4/SAS and MDM2. Our results thus exclude a common amplification target between CDK4/SAS and MDM2 and provide additional evidence that these genes represent two independent targets of selection.
Assuntos
Neoplasias Encefálicas/genética , Mapeamento Cromossômico/métodos , Cromossomos Humanos Par 12/genética , Quinases Ciclina-Dependentes/genética , Amplificação de Genes/genética , Glioblastoma/genética , Proteínas de Neoplasias/genética , Proteínas Nucleares , Proteínas Proto-Oncogênicas/genética , Adulto , Idoso , Quinase 4 Dependente de Ciclina , Sondas de DNA/genética , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Dados de Sequência Molecular , Proteínas Proto-Oncogênicas c-mdm2RESUMO
In human breast carcinomas, increased copy number of DNA sequences derived from the long arm of chromosome 20 (20q) has been commonly observed by both chromosome microdissection and comparative genomic hybridization. This chromosomal region is likely to contain one or more genes that are the biological targets of this amplification event. We describe here the utilization of a chromosome microdissection-hybrid selection strategy to isolate transcribed sequences from microdissected homogeneously staining regions encompassing 20q. Using this strategy, we have isolated three novel amplified genes (termed AIB1, AIB3, and AIB4) from a cDNA library constructed from the 20q amplified breast cancer cell line BT-474. These three genes were mapped to 20q11 (AIB3 and AIB4) and 20q12 (AIB1) by fluorescence in situ hybridization. Our results indicate an unsuspected complexity to the amplification pattern of 20q in breast cancer and provide probes that will be useful for further characterization of tumor specimens.
Assuntos
Neoplasias da Mama/genética , Cromossomos Humanos Par 20 , DNA de Neoplasias/genética , Sequência de Bases , DNA de Neoplasias/análise , DNA de Neoplasias/isolamento & purificação , Amplificação de Genes , Humanos , Hibridização in Situ Fluorescente , Dados de Sequência Molecular , Transcrição Gênica , Células Tumorais CultivadasRESUMO
Gene amplification is one of the major mechanisms of oncogene activation in tumorigenesis. To facilitate the identification of genes mapping to amplified regions, we have used a technique based on the hybridization of total genomic DNA to cDNA microarrays. To aid detection of the weak signals generated in this complex hybridization, we have used a tyramide-based technique that allows amplification of a fluorescent signal up to 1000-fold. Dilution experiment suggests that amplifications of 5-fold and higher can be detected by this approach. The technique was validated using cancer cell lines with several known gene amplifications, such as those affecting MYC, MYCN, ERBB2, and CDK4. In addition to the detection of the known amplifications, we identified a novel amplified gene, ZNF133, in the neuroblastoma cell line NGP. Hybridization of NGP cDNA on an identical array also revealed over expression of ZNF133. Parallel analysis of genomic DNA for copy number and cDNA for expression now provides rapid approach to the identification of amplified genes and chromosomal regions in tumor cells.
Assuntos
DNA Complementar/genética , Amplificação de Genes , Hibridização de Ácido Nucleico , Oncogenes , Proteínas Proto-Oncogênicas , Quinase 4 Dependente de Ciclina , Quinases Ciclina-Dependentes/genética , Genes erbB-2 , Genes myc , Humanos , Células Tumorais CultivadasRESUMO
To investigate the phenotype associated with estrogen receptor alpha (ER) expression in breast carcinoma, gene expression profiles of 58 node-negative breast carcinomas discordant for ER status were determined using DNA microarray technology. Using artificial neural networks as well as standard hierarchical clustering techniques, the tumors could be classified according to ER status, and a list of genes which discriminate tumors according to ER status was generated. The artificial neural networks could accurately predict ER status even when excluding top discriminator genes, including ER itself. By reference to the serial analysis of gene expression database, we found that only a small proportion of the 100 most important ER discriminator genes were also regulated by estradiol in MCF-7 cells. The results provide evidence that ER+ and ER- tumors display remarkably different gene-expression phenotypes not solely explained by differences in estrogen responsiveness.
Assuntos
Neoplasias da Mama/genética , Neoplasias da Mama/metabolismo , Redes Neurais de Computação , Análise de Sequência com Séries de Oligonucleotídeos , Receptores de Estrogênio/biossíntese , Neoplasias da Mama/patologia , Calibragem , Linhagem da Célula , Análise por Conglomerados , Estradiol/farmacologia , Receptor alfa de Estrogênio , Feminino , Expressão Gênica/efeitos dos fármacos , Perfilação da Expressão Gênica , Regulação Neoplásica da Expressão Gênica , Humanos , Modelos Genéticos , Fenótipo , Receptores de Estrogênio/genética , Reprodutibilidade dos Testes , Células Tumorais CultivadasRESUMO
Gastrointestinal stromal tumors (GISTs), the most common mesenchymal tumors of the digestive tract, are believed to arise from the interstitial cells of Cajal. GISTs are characterized by mutations in the proto-oncogene KIT that lead to constitutive activation of its tyrosine kinase activity. The tyrosine kinase inhibitor STI571, active against the BCR-ABL fusion protein in chronic myeloid leukemia, was recently shown to be highly effective in GISTs. We used 13,826-element cDNA microarrays to define the expression patterns of 13 KIT mutation-positive GISTs and compared them with the expression profiles of a group of spindle cell tumors from locations outside the gastrointestinal tract. Our results showed a remarkably distinct and uniform expression profile for all of the GISTs. In particular, hierarchical clustering of a subset of 113 cDNAs placed all of the GIST samples into one branch, with a Pearson correlation >0.91. This homogeneity suggests that the molecular pathogenesis of a GIST results from expansion of a clone that has acquired an activating mutation in KIT without the extreme genetic instability found in the common epithelial cancers. The results provide insight into the histogenesis of GIST and the clinical behavior of this therapeutically responsive tumor.